Halma reports full-year results and proposes higher final dividend

HLMA

Halma Plc (LON:HLMA), the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, has announced its full-year results for the 12 months to 31 March 2026

Halma’s results, together with other information about Halma, will be available on its corporate website, www.halma.com, and the results have been submitted in full unedited text to the Financial Conduct Authority’s National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

The webcast of the results presentation will be available on Halma’s website later today: www.halma.com

Dividends

The Board is recommending a 7% increase in the final dividend to 15.11p per share (2025: 14.12p per share). Together with the 9.63p per share interim dividend, this will give a total dividend per share of 24.74p (2025: 23.12p).

The final dividend for the financial year ended 31 March 2026 is subject to approval by shareholders at the Annual General Meeting on 23 July 2026 and, if approved, will be paid on 14 August 2026 to shareholders on the register at 10 July 2026.

The Company offers a Dividend Reinvestment Plan (‘DRIP’) to enable shareholders to elect to have their cash dividends reinvested in Halma plc shares. Shareholders who wish to opt for the DRIP for the forthcoming final dividend should return a DRIP mandate form to the Company’s Registrar no later than 24 July 2026.



Ex-dividend date for 2026 final dividend

Thursday 9 July 2026

Record date for 2026 final dividend

Friday 10 July 2026

Annual General Meeting

Thursday 23 July 2026

Final date for DRIP election

Friday 24 July 2026

Payment date

Friday 14 August 2026

Share on:

Latest Company News

Halma raises profit margin guidance after strong first half

Halma expects a 23.5%–24% Adjusted EBIT margin for 2027 after strong first-half growth and £515m of acquisitions....

Halma to acquire water quality monitoring specialist Pyxis for $170m

Halma has agreed to acquire Pyxis, a US-based provider of water quality monitoring and analysis technology, for an initial...

Halma completes sale of NovaBone for $60m

Halma has completed the sale of NovaBone Products LLC and its subsidiaries to Isto Biologics for total consideration of...

Halma expands healthcare portfolio with Dreampath acquisition

Halma has announced the acquisition of Dreampath, adding tissue sample traceability and storage capabilities to its Healthcare Sector....

Halma reports full-year results and proposes higher final dividend

Halma has released full-year results for the year to 31 March 2026 and proposed a higher final dividend....

Halma acquires ophthalmic instruments maker Surgistar for $90m

Halma has acquired California-based Surgistar, a manufacturer of ophthalmic surgical instruments and devices, for $90 million as a bolt-on...

    Search